Pelvic metastatic squamous cell carcinoma of unknown primary site: A case report and brief literature review

被引:2
作者
Zhu, Qi-Zhou [1 ]
Li, Hui-Juan [2 ]
Li, Yuan-Qiang [1 ]
Yu, Xiao-Hong [3 ]
Shu, Kuan-Yong [1 ,4 ]
机构
[1] Jiangxi Maternal & Child Hlth Hosp, Dept Gynecol Oncol, Nanchang, Jiangxi, Peoples R China
[2] Jiangxi Maternal & Child Hlth Hosp, Med Dept, Nanchang, Jiangxi, Peoples R China
[3] Jiangxi Maternal & Child Hlth Hosp, Dept Pathol, Nanchang, Jiangxi, Peoples R China
[4] Jiangxi Maternal & Child Hlth Hosp, Dept Gynecol Oncol, Nanchang 330006, Jiangxi, Peoples R China
关键词
pelvic metastatic; squamous cell carcinoma; unknown primary site; CANCER; SURVIVAL; BLOCKADE; PET/CT; TUMORS;
D O I
10.1097/MD.0000000000036796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale:Cancer with unknown primary site is a kind of disease that is difficult to deal with clinically, accounting for 2% to 9% of all newly diagnosed cancer cases. Here, we report such a case with pelvic metastatic squamous cell carcinoma of an unknown primary site and review the relevant literature.Patient concerns & Diagnoses:A 43-year-old Chinese female patient was referred to our hospital and initially diagnosed as "malignant tumor of right adnexal area?, obstruction of right ureter, secondary hydronephrosis".Interventions:Thereafter cytoreductive surgery was performed which included a total hysterectomy, left adnexectomy, partial omentum resection, pelvic lymph node dissection, and para-aortic lymph node dissection. The primary lesion could not be identified by supplementary examination and postoperative pathology. The patient was diagnosed as pelvic metastatic squamous cell carcinoma whose primary site was unknown. To prevent a recurrence, we administered adjuvant chemotherapy for the patient.Outcomes:The patient was followed up after treatment, complete remission has been maintained for 72 months, and no recurrence or metastasis has been found.Lessons:Our case demonstrates that surgery combined with chemotherapy could be helpful for pelvic metastatic squamous cell carcinoma of unknown primary site.
引用
收藏
页数:5
相关论文
共 20 条
[1]   Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling [J].
Binder, Carmen ;
Matthes, Katarina Luise ;
Korol, Dimitri ;
Rohrmann, Sabine ;
Moch, Holger .
CANCER MEDICINE, 2018, 7 (09) :4814-4824
[2]   Unknown primary site of serous papillary adenocarcinoma involving inguinal, iliac and obturator lymph nodes co-existing with endometrial adenocarcinoma [J].
Burbos, N. ;
Blanas, K. ;
Epurescu, S. D. ;
Lonsdale, R. ;
Nieto, J. J. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (05) :542-543
[3]   Unknown primary [J].
Chorost, MI ;
Lee, MC ;
Yeoh, CB ;
Molina, M ;
Ghosh, BC .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 87 (04) :191-203
[4]   Docetaxel and Cisplatin in First Line Treatment of Patients with Unknown Primary Cancer: A Multicenter Study of the Anatolian Society of Medical Oncology [J].
Demirci, Umut ;
Coskun, Ugur ;
Karaca, Halit ;
Dane, Faysal ;
Ozdemir, Nuriye Yildirim ;
Ulas, Arife ;
Baykara, Meltem ;
Benekli, Mustafa ;
Ozkan, Metin ;
Buyukberber, Suleyman .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (04) :1581-1584
[5]   Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy [J].
Gatalica, Zoran ;
Xiu, Joanne ;
Swensen, Jeff ;
Vranic, Semir .
EUROPEAN JOURNAL OF CANCER, 2018, 94 :179-186
[6]   Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model [J].
Greco, F. Anthony .
NATURE REVIEWS CANCER, 2014, 14 (01) :3-4
[7]   Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site [J].
Hayashi, Hidetoshi ;
Kurata, Takayasu ;
Takiguchi, Yuichi ;
Arai, Makoto ;
Takeda, Koji ;
Akiyoshi, Kohei ;
Matsumoto, Koji ;
Onoe, Takuma ;
Mukai, Hirofumi ;
Matsubara, Nobuaki ;
Minami, Hironobu ;
Toyoda, Masanori ;
Onozawa, Yusuke ;
Ono, Akira ;
Fujita, Yoshihiko ;
Sakai, Kazuko ;
Koh, Yasuhiro ;
Takeuchi, Ayano ;
Ohashi, Yasuo ;
Nishio, Kazuto ;
Nakagawa, Kazuhiko .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07) :570-+
[8]   Treatment of epithelial ovarian cancer [J].
Kuroki, Lindsay ;
Guntupalli, Saketh R. .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
[9]   PD-1 Blockade in Tumors with Mismatch-Repair Deficiency [J].
Le, D. T. ;
Uram, J. N. ;
Wang, H. ;
Bartlett, B. R. ;
Kemberling, H. ;
Eyring, A. D. ;
Skora, A. D. ;
Luber, B. S. ;
Azad, N. S. ;
Laheru, D. ;
Biedrzycki, B. ;
Donehower, R. C. ;
Zaheer, A. ;
Fisher, G. A. ;
Crocenzi, T. S. ;
Lee, J. J. ;
Duffy, S. M. ;
Goldberg, R. M. ;
de la Chapelle, A. ;
Koshiji, M. ;
Bhaijee, F. ;
Huebner, T. ;
Hruban, R. H. ;
Wood, L. D. ;
Cuka, N. ;
Pardoll, D. M. ;
Papadopoulos, N. ;
Kinzler, K. W. ;
Zhou, S. ;
Cornish, T. C. ;
Taube, J. M. ;
Anders, R. A. ;
Eshleman, J. R. ;
Vogelstein, B. ;
Diaz, L. A., Jr. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2509-2520
[10]   Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis [J].
Lee, J. ;
Hahn, S. ;
Kim, D-W ;
Kim, J. ;
Kang, S. N. ;
Rha, S. Y. ;
Lee, K. B. ;
Kang, J-H ;
Park, B-J .
BRITISH JOURNAL OF CANCER, 2013, 108 (01) :39-48